HOME > TOP STORIES
TOP STORIES
-
BUSINESS Chugai to Enter Hemophilia Field with Emicizumab; Peak Sales Could Top 200 Billion Yen
December 6, 2016
-
REGULATORY PM Abe’s Council to Discuss Annual Drug Price Revisions Again on Dec. 7
December 5, 2016
-
INTERVIEW Interview: Metgluco, AGs, and Diagnostics 3 Biz Pillars for New Sumitomo Dainippon Subsidiary
December 2, 2016
-
REGULATORY Industry, Healthcare Provider Reps Oppose “Annual Revisions” as Payers Hold Off Stance: Chuikyo
December 1, 2016
-
REGULATORY Chuikyo to Discuss “Price-Setting Including NHI Price Increases” Using Cost-Effective Assessments
December 1, 2016
-
REGULATORY “Outright” or “Partial”? Annual Revision Debate Rekindled in a Rush to Revamp Drug Pricing
November 30, 2016
-
BUSINESS Signs of Growth in Prescribing SGLT-2 Inhibitors with Favorable Environment Change
November 30, 2016
-
BUSINESS Ono to Offer New Invoice Prices for Opdivo Early on to Avoid Distribution Confusion
November 29, 2016
-
REGULATORY Annual Price Revision Push Gaining Momentum; PM Wants Pricing Revamp Policy by Year-End
November 28, 2016
-
BUSINESS Drug Makers Concerned about Cost-Effective Assessments Used for NHI Price Cuts: Survey
November 28, 2016
-
REGULATORY Keytruda Clears MHLW Panel for Both 1st-Line, 2nd-Line NSCLC
November 25, 2016
-
BUSINESS 27 Japan Drug Makers Eke Out Profit despite Logging Lower Sales on FX, Price Cuts: Jiho Tally
November 24, 2016
-
REGULATORY MHLW to Announce Opdivo’s New Prices on Nov. 24
November 24, 2016
-
BUSINESS Taltz Finally Makes it to Japan Market after Pricing Flap
November 22, 2016
-
BUSINESS 3 Japan Generic Majors See Subdued Sales Rise in April-September
November 21, 2016
-
REGULATORY MHLW to Kick Off Discussions for Major Drug Pricing Overhaul by Year-End: Bureau Chief
November 18, 2016
-
REGULATORY 50% Price Cut for Opdivo OK’ed with Estimated Sales of 151.6-Plus Billion Yen
November 17, 2016
-
REGULATORY ICH Eyes Major GCP Revamp with Use of Real World Data: Osaka Confab
November 16, 2016
-
REGULATORY Opdivo’s NHI Price-Based Sales Put at Over 151 Billion Yen; 50% Cut Likely to Take Effect Feb. 1
November 15, 2016
-
TRENDS AGs Set to Break into 10 Billion Yen Territory in Japan
November 14, 2016
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
